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ABSTRACT
Introduction Big data research has grown 
considerably over the last two decades. This presents 
new ethical challenges around consent, data storage 
and anonymisation. Big data research projects 
require public support to succeed and it has been 
argued that one way to achieve this is through public 
involvement and engagement. To better understand 
the role public involvement and engagement can 
play in big data research, we will review the current 
literature. This protocol describes the planned review 
methods.
Methods and analysis Our review will be conducted 
in two stages. In the first stage, we will conduct a 
scoping review using Arksey and O’Malley methodology 
to comprehensively map current evidence on public 
involvement and engagement in big data research. 
Databases (CINAHL, Health Research Premium 
Collection, PubMed, Scopus, Web of Science) and 
grey literature will be searched for eligible papers. We 
provide a narrative description of the results based on 
a thematic analysis. In the second stage, out of papers 
found in the scoping review which discuss involvement 
and engagement strategies, we will conduct a 
systematic review following Preferred Reporting 
Items for Systematic Reviews and Meta- Analyses 
guidelines, exploring the delivery and effectiveness 
of these strategies. We will conduct a qualitative 
synthesis. Relevant results from the quantitative 
studies will be extracted and placed under qualitative 
themes. Individual studies will be appraised through 
Mixed Methods Appraisal Tool (MMAT), we will then 
assess the overall confidence in each finding through 
Confidence in the Evidence from Reviews of Qualitative 
research (GRADE- CERQual). Results will be reported in 
a thematic and narrative way.
Ethics and dissemination This protocol sets out 
how the review will be conducted to ensure rigour 
and transparency. Public advisors were involved in 
its development. Ethics approval is not required. 
Review findings will be presented at conferences and 
published in peer- reviewed journals.
INTRODUCTION
What is the problem?
Over the last two decades, the ongoing digi-
talisation of information has allowed the 
creation and linkage of large, multi- source 
health data sets to provide novel healthcare 
applications. This is often called ‘big data’, 
but the concept itself is unclear and heavily 
debated.1 However, this growing area of 
research has the following characteristics: 
large volume, high velocity, huge variety, 
veracity and value.1 Multiple stakeholders 
use big data for research; clinical manage-
ment; audit; service evaluation or statistical 
purposes. The UK has been a global leader in 
big data research. Large projects include, at 
national level, OpenSAFELY2 and regionally 
located projects such as Children Growing 
Up in Liverpool3 (to name a few). The over- 
riding aims of big data research projects are 
to deliver more efficient healthcare,4 and to 
reduce health inequalities.5
The use of big data for research presents 
ethical challenges.6 Traditionally, a person 
consents to participate in a research study, 
whereas when large quantities of data are 
collected, it is not often apparent how it will be 
(re)used in the future. Data can be collected 
for one purpose (eg, audit or to collect groups 
statistics) and only later shared or linked for 
Strengths and limitations of this study
 ► This is the first review exploring public involvement 
and engagement in big data research.
 ► The search is limited to studies published in English.
 ► Lack of clarity and consistency with the use of the 
terms public involvement, engagement and big data 
could impact our search results. However, we will 
undertake additional searching techniques to miti-
gate this limitation.
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research. Second, even when big data is anonymised, in 
theory, individuals can be still re- identified.6 Third, digi-
talised data needs to be stored—sometimes in various 
places and hosted by both public institutions and private 
companies. Despite these ethical issues (consent, anony-
misation, data storage and access), the literature shows 
that the public mostly supports big data usage in research,7 
but is sceptical toward current governance mechanisms8 
and concerned about associated risks such as breach of 
privacy, generating waste of unused information and 
usage of data for profit rather than for the public good. 
Big data is still new, and thus it often outpaces governance 
structures and regulation. Even if researchers meet the 
legal requirements, the public might not be supportive 
of their actions.9 10 Controversial cases can undermine 
public trust in big data. For example, the case of Deep-
Mind in the UK illustrated these dangers: the project 
breached data protection legislation by sharing patients’ 
data (without properly informing them) with the Google- 
owned company.11 Low public engagement and lack of 
transparency in the  care. data project in the UK12 led to 
its eventual closure. The public might perceive the risk–
benefit ratio as unfavourable for them and therefore not 
want to support or participate in the research. Also, it 
could foster general distrust in healthcare professionals.
What is the solution?
The concept of trust is vital in building a positive rela-
tionship between researchers and the public.8 Improving 
people’s knowledge, through public engagement, of how 
big data research works can improve public support for 
using health data.13 For example, the #DataSavesLives 
initiative raises awareness of the benefits of health data 
research to gain public trust.14 Second, researchers 
should involve the public in developing transparent, 
accountable policies and governance processes.15 Public 
involvement and engagement are crucial mechanisms 
to develop governance policies and build trust between 
the public and researchers. Public involvement should be 
genuine. It should not be carried out with the sole aim 
of benefiting researchers; be tokenistic or mislead the 
public.16 Extensive evidence shows that successful public 
involvement can lead to service improvement,17–20 raises 
awareness of services20 and brings together patients’ and 
researchers’ priorities.21
Public involvement in big data research has context- 
related challenges. In traditional research, a participant 
and a researcher would have some contact. In contrast, 
big data research includes large groups of people (who 
might not necessarily be aware that a particular research 
team uses their data), thus creating a feeling of remote-
ness between researchers and the public.10 Therefore, 
building trust between the public and researchers is more 
challenging. Transparent governance policies need to be 
developed with public involvement to ensure transpar-
ency. Lay people can be members of ethics and gover-
nance committees overseeing research projects, ensuring 
public voices are heard. Researchers need big data 
specific recommendations on involving and engaging 
the public. However, the literature on public involvement 
and engagement in big data research is still limited.
Why is this review needed?
Systematic and narrative reviews that have explored the 
public attitudes towards big data have typically focused on 
trust or attitudes towards using big data for research.7 22–24 
However, how and to what extent public involvement 
and engagement is used in establishing trust for big data 
research (eg, organising and maintaining large health 
data sets and its governance policies) has received less 
attention. To our knowledge, there is no review covering 
our objectives published or registered on PROSPERO or 
Cochrane databases.
To better understand the complexity of public involve-
ment and engagement in big data research, we developed 
a system logic model (see figure 1) following Rohwer et al 
guidance.25 Graphic presentations (such as logic models) 
can be used in reviews to identify relevant elements and 
the relationships between them. This model is based on 
team discussion, a preliminary scoping of literature, and 
public advisors’ feedback. We used asterisks (*) to record 
those sections which were suggested by public advisors. 
Our model puts special emphasis on four related sections: 
context, design of public involvement and engagement 
strategies, targeted population and outcomes. As our 
review progresses, we will develop the logic model, and 
present the final version in the report of our review’s find-
ings. We hope that the model will assist in interpreting 
the findings and identifying gaps in the literature.
Review objectives
The purpose of this review is to synthesise the evidence on 
public involvement and engagement in big data research. 
We have two objectives:
 ► Comprehensively map current evidence on public 
involvement and engagement in big data research 
(scoping review).
 ► Use this to synthesise evidence on the delivery and 




The review will be conducted in two stages as illustrated 
in figure 2.26 These stages will complement each other 
and assist in flexibly understanding the phenomenon. 
First, the literature on public involvement and engage-
ment in big data research will be explored by conducting 
a scoping review. We follow Arksey and O’Malley27 frame-
work and its further iterations.28 29 The scoping review will 
allow us to clarify concepts, illustrate current evidence in 
the field and gaps in research.30 In the second stage, out 
of papers identified in the scoping review, we will extract 
those discussing involvement and engagement strategies 
to explore their delivery and effectiveness. The findings 
from the systematic review will inform researchers on best 
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practice and identify any conflicting views.30 To further 
enhance the quality of this review, we follow Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) reporting guidelines.31
Stage 1: scoping review
Search strategy
We will search the following databases CINAHL, Health 
Research Premium Collection, PubMed, Scopus, Web of 
Science and check sources of grey literature related to 
public involvement such as the Patient- Centred Outcome 
Research Institute. The first hundred hits (to be inclu-
sive but practical) of Google Scholar search results will be 
scanned for inclusion. We will also hand- search papers in 
the journals Health Expectations, BMC Research Involvement 
and Engagement and the International Journal of Population 
Data Science. This will be followed by snowball sampling 
where we will check references in included papers to 
identify additional studies for inclusion and consult with 
experts about relevant papers. Big data research is a newly 
developing field; for instance, MeSH terms ‘big data’ was 
added in 2019. Thus, to capture these recent develop-
ments, we will restrict searches to a start date of 2010 and 
will update our searches prior to the final submission of 
our findings.
We developed the search strategy in partnership with an 
information specialist and tested this through an iterative 
process. It consists of both Boolean operators and where 
possible MeSH (PubMed) or subject heading (CINAHL). 
Three databases were searched in a test run and yielded a 
large number of references that were not relevant to our 
review aims. Therefore, we decided to include the further 
term ‘data governance’ as we expect that most of the 
public involvement and engagement in big data research 
would be at the stage of developing and maintaining data 
sets. The summary of the search strategy is presented in 
table 1.
Inclusion and exclusion criteria in the scoping review
Public involvement and engagement can take place at any 
stage of a big data research project. Thus, we will include 
papers relating to any public role or contribution to big 
data research. These roles can include permission to use 
data, involvement in defining aims or design, and partici-
pation in decision- making processes (also the public may 
become members of a research team).16
Previous reviews17 32 33 have noted that a lack of one 
generally accepted definition of public involvement 
makes searching databases challenging. Hence, the defi-
nition of public involvement and engagement in the 
literature lacks consistency.20 Involvement, engagement, 
participation are often used interchangeably in the liter-
ature but do not necessarily have the same meaning.34 
We follow the INVOLVE definition of public involvement 
and engagement.35
Public involvement
‘Research being carried out ‘with’ or ‘by’ members of the 
public rather than ‘to’, ‘about’ or ‘for’ them’.
Figure 1 System logic model of public involvement and engagement in big data research. HCP, healthcare professionals; PPI, 
public and patient involvement.
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Consultation
Researchers discussed the project with members of the 
public. It was more of ‘to’, ‘about’ or ‘for’ rather than 
‘with’ or ‘by’ them.
Public engagement
‘Information and knowledge about research is provided 
and disseminated’—this usually takes place after the 
project is concluded.
INVOLVE’s definition of involvement sees an equal 
relationship between researchers and the public. Thus, 
involvement should mean codesign and coproduc-
tion rather than just consultation. However, we will not 
exclude papers that do not meet this requirement but 
note it. Thus, included papers will be assigned one of 
three named categories: green (when it meets the defi-
nition of public involvement), blue (when consultation 
took place) and amber (where only the engagement 
occurred).
Multiple definitions of big data exist.1 To broadly map 
the current evidence, we use a definition which focuses 
on big data in the healthcare setting.
Big data
Data which is challenging to manage through traditional 
analytic tools and meets the 5V characteristics: volume, 
velocity, variety, veracity and value.1
The volume suggests that there may be a high quan-
tity of data available potentially on millions of patients. 
The variety means heterogeneity of data collected as it 
can come in various formats (eg, images, text). The 
velocity means that it can be collected swiftly from various 
sources. Veracity relates to the accuracy and identifica-
tion of any biases. The value refers to the ability of results 
from research based on big data to guide decisions. Big 
data sources can be internal (eg, patients record, health-
care professional notes, generated through apps or social 
media) and external (eg, private companies or govern-
mental institutions).
To map a range of studies, we will keep the selection 
criteria purposefully broad. Papers can discuss single 
research project or data sharing initiative. All study designs 
will be included. Papers can be (but not limited to) orig-
inal research, an evaluation, a review, an expert opinion 
or a commentary that explores any public involvement 
and engagement in big data research.
We will exclude a paper if it:
 ► Does not discuss public involvement or engagement.
 ► Does not discuss a patient- related (or health- related) 
application.
 ► The full text is not available in English.
Figure 2 Systematic map of the review process. GRADE- 
CERQual, Confidence in the Evidence from Reviews of 
Qualitative research; MMAT, Mixed Methods Appraisal Tool.
Table 1 Search strategy
Public “advisory group” OR carer* OR 
citizen* OR client* OR communit* 
OR consumer* OR famil* OR lay 
OR nonpatient* OR participant* OR 
patient* OR public OR relative* OR 
representative* OR stakeholder* OR 




advocacy OR collaborat* OR 
co*production OR consult* OR 
empower* OR engage* evaluat* OR 
involv* OR particip* OR partner* 
OR PPI OR organi*ation* OR 
representation*
Big data database OR “big data” OR “data 
science” OR “data mining” OR 
“datasets” OR “data analytics” OR 
“data sets”
Public involvement “patient participation” OR “consumer 






and Web of 
Science)
“data governance”
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Study selection
Prior to the screening stage, we will organise a meeting 
for everyone involved in the study selection process 
during which we will jointly scan a sample of 100 papers. 
We will record and discuss our disagreements. Then sepa-
rately, we will scan all papers’ eligibility, based on the title 
and then the abstract identified in the database searches. 
At each stage, two reviewers will be involved. The first 
reviewer will scan all papers and the second will check a 
random sample (20% of all papers). Reasons for exclu-
sion will be recorded. If there are any disagreements, we 
will include a third reviewer. Then the full text will be 
screened by two reviewers, checking if the paper meets 
the inclusion and exclusion criteria. We will meet after 
each screening stage (title, abstract and full paper) to 
discuss our experiences.
Data extraction
We will use an extraction form which will cover the 
following information:
 ► Paper aim.
 ► Design.
 ► Country.
 ► Demographics of participants (also record if there are 
a seldom- heard group).
 ► Context.
 ► Process of involvement or engagement.
 ► Funding.
 ► Legal or ethical issues.
 ► References to guidance and policies.
 ► Challenges and facilitators of public involvement and 
engagement.
We see the extraction stage as an iterative process. After 
extracting initial papers, we will discuss if the extraction 
form is applicable in our review during team meetings. 
Where necessary, we will revise it. Each paper will be 
extracted by one reviewer and the second will validate 
data extraction.
Reporting the results
We will provide a descriptive and narrative analysis of the 
data. These will be used to develop the system model. 
Then, we will discuss the implication of the findings for 
researchers and policy.
Stage 2: systematic review
Criteria for inclusion
Out of papers identified in the scoping review, we will 
extract qualitative and quantitative studies that discuss 
the delivery or effectiveness of involvement and engage-
ment strategies.
Data extraction and synthesis
We will follow Thomas and Harden36 stages of qualitative 
synthesis. We plan to extract all findings sections from 
included papers and upload them to NVivo for analysis. 
Coding will be done inductively to develop descriptive 
themes to further our review aims and develop the system 
model. Thus, we want to ensure that no prior framework 
will influence us in identifying the relevant evidence. 
The relevant results from the quantitative studies will 
be extracted and placed under qualitative themes, as we 
do not expect that meta- analysis will be possible. At the 
last stage of the synthesis, we go beyond the descriptive 
themes and analyse them in the context of the aims of our 
review. The results will be provided in a thematic, narra-
tive way and used to develop the system model.
Studies and findings appraisal
Using Mixed Methods Appraisal Tool (MMAT)37 we will 
systematically appraise all studies included in the system-
atic review. However, no paper will be excluded if it scored 
low. The overall confidence in each individual qualitative 
findings will be assessed through the Confidence in the 
Evidence from Reviews of Qualitative Research (GRADE- 
CERQual).38 We will not assess the overall confidence in 
quantitative studies as these will be placed under the qual-
itative themes. This will allow researchers to make judge-
ments about the quality of available evidence.
Patient and public involvement
Stakeholders (including patients and health profes-
sionals) can be involved in systematic reviews.39 40 They 
can enhance the quality of the review by advising on the 
review questions and its scope. This ensures transparency 
and accountability, especially if the review aims to shape 
practice and improves relevance to those who this review 
seeks to influence (eg, practitioners and public). Simi-
larly, for scoping reviews. Arksey and O’Malley27 recom-
mend, and Levac et al29 argue that consultation is a part 
of the review process. We have involved two public advi-
sors who assisted in designing this protocol and will be 
coauthors on all publications. They have experience of 
conducting systematic reviews, represent seldom- heard 
communities and SA is a Big Data Ambassador for Care 
and Health Informatics theme within ARC NWC. They 
will be involved in the whole review process, with a partic-
ular emphasis on interpreting the findings and devel-
oping recommendations for both research and practice. 
We will report on public involvement using the Guidance 
for Reporting Involvement of Patients and the Public 
(GRIPP2) checklist.41
Limitations
The main limitation of our review is the exclusion of non- 
English papers. There is a possibility that some papers 
relevant to our review aims will be excluded and this 
will impact our findings. Second, as already mentioned 
the lack of clear definitions of public involvement, 
engagement and big data make any search strategy chal-
lenging, and potentially some relevant papers might not 
be included. However, we will undertake all reasonable 
steps to balance this limitation by involving experts and 
checking references in included papers.
Ethics and dissemination
We have published this protocol and engaged with public 
advisors to ensure transparency and rigour of our review 
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process. As we are using already published data, there 
is no need to apply for ethical approval to conduct our 
study. We will present our findings at relevant confer-
ences and publish in a peer- reviewed journal.
DISCUSSION
This review will synthesise the current literature on public 
involvement and engagement in big data research. Our 
work is timely as it is expected that big data research in 
healthcare will continue to grow rapidly. There will be 
increasing interest in developing large health data sets by 
researchers, funders and governmental bodies. Previous 
research shows the need for synthesising the current 
evidence. Mouton et al42 discussed issues around patient 
trust and big data, and how they viewed healthcare prac-
titioners and professionals’ involvement in funding or 
controlling big data research. They believed that patients 
were not interested or did not understand big data—and 
therefore, should not be involved in its governance. Their 
comments included remarks that patient groups are 
not important and the belief that patients’ involvement 
in governance would be pointless. On the other hand, 
Aitken et al8 explored the similar issues with members of 
the public who presented opposite views on lay involve-
ment in data governance. Participants believed that 
members of the public could promote accountability of 
big data research. Public involvement has the potential to 
shift perspectives and bridge the gap between researchers 
and the public, and help the development of big data 
research that has wider spread public support and buy- in.
Twitter Piotr Teodorowski @PTeodorowski, Naheed Tahir @NaheedandTahir and 
Lucy Frith @lucy_frith
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